P Murry - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

P Murry

Showing results (31-40 of 33) with videos related to

Pageof 4

Sort By:

You have reached the last page of results.This site can display upto 33 results.

Nature Communications|June 17, 2022

Therapeutic efficacy of combined active and passive immunization in ART-suppressed, SHIV-infected rhesus macaquesVictoria E K Walker-Sperling, Noe B Mercado, Abishek Chandrashekar, et al.

NPJ Vaccines|May 18, 2022

Therapeutic efficacy of an Ad26/MVA vaccine with SIV gp140 protein and vesatolimod in ART-suppressed rhesus macaquesJohn D Ventura, Joseph P Nkolola, Abishek Chandrashekar, et al.

Plos Pathogens|April 16, 2016

A Subset of Latency-Reversing Agents Expose HIV-Infected Resting CD4+ T-Cells to Recognition by Cytotoxic T-LymphocytesR Brad Jones, Stefanie Mueller, Rachel O'Connor, et al.

Pageof 4

Search research articles

Showing results (31-40 of 33) with videos related to

Sort By:

Pageof 4

You have reached the last page of results.This site can display upto 33 results.

Nature Communications|June 17, 2022

Therapeutic efficacy of combined active and passive immunization in ART-suppressed, SHIV-infected rhesus macaquesVictoria E K Walker-Sperling, Noe B Mercado, Abishek Chandrashekar, et al.

NPJ Vaccines|May 18, 2022

Therapeutic efficacy of an Ad26/MVA vaccine with SIV gp140 protein and vesatolimod in ART-suppressed rhesus macaquesJohn D Ventura, Joseph P Nkolola, Abishek Chandrashekar, et al.

Plos Pathogens|April 16, 2016

A Subset of Latency-Reversing Agents Expose HIV-Infected Resting CD4+ T-Cells to Recognition by Cytotoxic T-LymphocytesR Brad Jones, Stefanie Mueller, Rachel O'Connor, et al.

Pageof 4